Taisho Pharmaceutical Holdings Co., Ltd.
Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) Stock Overview
Explore Taisho Pharmaceutical Holdings Co., Ltd.’s financial performance, market position, analyst ratings, and future outlook.
Key Financials
Key Financials
Market Cap
18.1B
P/E Ratio
2.41
EPS (TTM)
$0.17
ROE
0.02%
TAIPY Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of Taisho Pharmaceutical Holdings Co., Ltd. (TAIPY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
Our forecasting models predict significant price movements, with a 12-month target of $22.51.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 2.41 and a market capitalization of 18.1B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.